Offer - Urjas Oil for just ₹ 1
Terpect 50/1.25/4 Tablet is a commercial drug that is prescribed in the form of Tablet. Secondary and off-label uses of Terpect 50/1.25/4 Tablet have also been mentioned below.
Medical history of the patient along with age and gender determines the dosage of Terpect 50/1.25/4 Tablet. The condition it has been prescribed for, and the route of administration also determine the right dosage. For detailed information on this, read through the dosage section.
Terpect 50/1.25/4 Tablet also has some side effects, the most common being Skin Rash, Epigastric Pain, Bronchospasm. Some other side effects of Terpect 50/1.25/4 Tablet have been listed ahead. Such side effects of Terpect 50/1.25/4 Tablet normally do not last long and go away once the treatment is completed. If, however, they worsen or do not go away, please speak with your physician.
In addition, Terpect 50/1.25/4 Tablet's effect is Severe during pregnancy and Severe for lactating mothers. It is important to know if Terpect 50/1.25/4 Tablet has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Terpect 50/1.25/4 Tablet related warnings section.
Terpect 50/1.25/4 Tablet is not recommended if you suffer from certain medical conditions as it can have adverse effects. Asthma, Smoking Addiction are examples of such conditions. Other conditions have been mentioned below in the Terpect 50/1.25/4 Tablet contraindications section.
Besides this, Terpect 50/1.25/4 Tablet may also have severe interaction with some medicines. A complete list of these interactions is given below.
Along with the above-mentioned precautions, remember that taking Terpect 50/1.25/4 Tablet is considered not safe while driving, and is not addictive.
Terpect 50/1.25/4 Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Is the use of Terpect 50/1.25/4 Tablet safe for pregnant women?
Terpect can cause severe side effects if taken during pregnancy, so, pregnant women should talk to their doctor before taking it.
Is the use of Terpect 50/1.25/4 Tablet safe during breastfeeding?
Taking Terpect may lead to serious side effects if you are breastfeeding. Terpect should not be taken by breastfeeding women unless prescribed by the doctor.
What is the effect of Terpect 50/1.25/4 Tablet on the Kidneys?
There can be some harmful effects on your kidneys after taking Terpect. If you witness any side effects, discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Terpect 50/1.25/4 Tablet on the Liver?
Terpect is rarely harmful for the liver.
What is the effect of Terpect 50/1.25/4 Tablet on the Heart?
Side effects of Terpect rarely affect the heart.
If you are suffering from any of the following diseases, you should not take Terpect 50/1.25/4 Tablet unless your doctor advises you to do so -
Is this Terpect 50/1.25/4 Tablet habit forming or addictive?
Terpect 50/1.25/4 Tablet does not cause addiction.
Interaction between Food and Terpect 50/1.25/4 Tablet
Information is not available on the interaction of any foods with Terpect 50/1.25/4 Tablet, due to a lack of research on this.
Interaction between Alcohol and Terpect 50/1.25/4 Tablet
No research has been done on this till date. Therefore, it is not known what the effect of taking Terpect 50/1.25/4 Tablet with alcohol will be.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Guaifenesin
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 629-631
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 223
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1182-1183
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 219
